financetom
Business
financetom
/
Business
/
Oracle slides as it misses Wall Street revenue targets on tough cloud competition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oracle slides as it misses Wall Street revenue targets on tough cloud competition
Dec 10, 2024 3:15 AM

(Reuters) - Oracle's shares sank over 8% on Tuesday in premarket trading after its quarterly revenue fell short of expectations, hindered by fierce competition among database and cloud services providers.

The cloud computing company is on track to lose about $45 billion in market capitalization at current share price levels of $174.14, as per LSEG data.

Oracle's second-quarter revenue reached $14.06 billion, marking a 9% increase from the previous year, but below Wall Street estimates of $14.11 billion, as per data compiled by LSEG.

Oracle has been significantly investing in establishing new facilities, aiming to enhance its cloud infrastructure to cater to the growing demand for artificial intelligence and to bridge the gap with industry leaders.

Wall Street expectations for AI-linked firms have been high as they bet on the technology to be a strong growth driver in the future.

"With the rapid backlog build appearing to level out, investor focus likely shifts towards the income statement and Oracle's ability to convert this demand into accelerating revenues and durable double-digit EPS growth," Morgan Stanley analysts said in a note.

Despite experiencing robust growth in its cloud segment, Oracle faces stiff competition from cloud giants like Microsoft and Amazon, who have a significant foothold in the industry.

"Oracle cloud infrastructure revenue remains heightened as demand for AI compute grows on the platform," said D.A. Davidson in a note.

Oracle's 12-month forward price-to-earnings ratio is 28.08, lower than Microsoft's 31.86 and Amazon's 36.66.

The company's shares have soared over 80% so far this year, but Barclays cautioned the primary headwind to the stock, besides the recent strong share price performance, will potentially rely on the firm achieving its target of double-digit revenue growth for the full year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Serbia's NIS gets US approval to negotiate sale of Russian stake
Serbia's NIS gets US approval to negotiate sale of Russian stake
Mar 10, 2026
BELGRADE, Dec 24 (Reuters) - The U.S. has granted Serbian oil refiner NIS until March 24 to negotiate the sale of its ‌Russian owner's stake, Serbia's state-owned RTS TV ​reported on Wednesday. However, RTS said NIS ‍had not obtained an operating ⁠licence ⁠that would allow it to buy and process ‌crude oil. The U.S. ​Treasury Department's Office of Foreign Assets...
Arya Resources Raises $1.22 Million in Flow-through Financings of Shares
Arya Resources Raises $1.22 Million in Flow-through Financings of Shares
Mar 10, 2026
12:31 PM EST, 12/24/2025 (MT Newswires) -- Arya Resources (RBZ.V), up 11% on last look, said Wednesday it closed its flow-through financings, raising $1.22 million. The company issued 3.7-million tax-advantaged shares at $0.33 each. Proceeds will be used to advance exploration at the Wedge Lake Gold Project and Dunlop Project in Saskatchewan. Arya said its non-flow-through (NFT) financing is scheduled...
Biohaven's Major Depressive Disorder Candidate Fails to Meet Primary Endpoint in Phase 2 Study; Shares Fall After Hours
Biohaven's Major Depressive Disorder Candidate Fails to Meet Primary Endpoint in Phase 2 Study; Shares Fall After Hours
Mar 10, 2026
01:34 PM EST, 12/24/2025 (MT Newswires) -- Biohaven ( BHVN ) said Wednesday the phase 2 study evaluating BHV-7000 for the treatment of major depressive disorder failed to meet its primary endpoint. The proof-of-concept trial's main goal was the reduction of depressive symptoms as measured by change in the Montgomery Asberg Depression Rating Scale over six weeks compared with placebo,...
Seagate Technology Hldgs Unusual Options Activity For December 24
Seagate Technology Hldgs Unusual Options Activity For December 24
Mar 10, 2026
Deep-pocketed investors have adopted a bearish approach towards Seagate Technology Hldgs ( STX ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in STX usually suggests something big is about to happen. We gleaned this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved